tiprankstipranks
Alpine Immune Sciences downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyAlpine Immune Sciences downgraded to Market Perform from Outperform at Leerink
14d ago
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
PremiumThe Fly
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
14d ago
DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls
PremiumThe Fly
DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls
14d ago
Alpine Immune downgraded to Sector Perform from Outperform at RBC Capital
PremiumThe FlyAlpine Immune downgraded to Sector Perform from Outperform at RBC Capital
14d ago
M&A: Vertex Bolsters its Drug Portfolio with Alpine Deal
PremiumMarket News
M&A: Vertex Bolsters its Drug Portfolio with Alpine Deal
14d ago
Vertex to acquire Alpine Immune Sciences for $65 per share
PremiumThe Fly
Vertex to acquire Alpine Immune Sciences for $65 per share
15d ago
Vertex Pharmaceuticals advances inaxaplin into Phase 3 portion of trial
PremiumThe FlyVertex Pharmaceuticals advances inaxaplin into Phase 3 portion of trial
24d ago
Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
PremiumMarket News
Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
25d ago
Truist pharmaceuticals analyst holds an analyst/industry conference call
PremiumThe Fly
Truist pharmaceuticals analyst holds an analyst/industry conference call
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100